First-in-man study of dedicated bifurcation cobalt-chromium sirolimus-eluting stent BiOSS LIM C ® - three-month results.

CONCLUSIONS: Bifurcation treatment with a single dedicated bifurcation stent (BiOSS LIM C®) is feasible and highly successful (100% implantation success rate). The short-term clinical outcomes are very promising, also in distal left main stenosis. The 12-month observations are pending. PMID: 29192951 [PubMed - indexed for MEDLINE]

https://www.ncbi.nlm.nih.gov/pubmed/29192951?dopt=Abstract

Source: Kardiologia Polska - December 12, 2018 Category: Cardiology Authors: Gil RJ, Bil J, Kern A, Pawłowski T Tags: Kardiol Pol Source Type: research